Novo Holdings A/S - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$5,183,809
-28.8%
1,126,9150.0%0.38%
-32.0%
Q2 2023$7,279,871
-14.3%
1,126,9150.0%0.56%
+0.4%
Q1 2023$8,496,939
-25.6%
1,126,9150.0%0.56%
-21.3%
Q4 2022$11,415,649
+2.4%
1,126,9150.0%0.71%
+34.3%
Q3 2022$11,145,000
-7.1%
1,126,9150.0%0.53%
-10.2%
Q2 2022$12,002,000
+29.2%
1,126,915
+166.8%
0.59%
+43.4%
Q2 2021$9,292,000422,3820.41%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$75,584,00086.10%
Gruss & Co., LLC 430,407$8,625,00024.12%
SB Management Ltd 9,817,190$196,736,00020.16%
GUARDIAN CAPITAL ADVISORS LP 3,836,414$76,767,0007.97%
Intellectus Partners, LLC 1,223,429$24,518,0005.93%
HARVARD MANAGEMENT CO INC 4,105,095$82,266,0004.82%
ArchPoint Investors 461,289$9,244,0002.77%
Belmont Capital, LLC 150,000$3,006,0002.44%
CLOUGH CAPITAL PARTNERS L P 971,297$19,465,0001.18%
Orbimed Advisors 4,180,768$83,783,0000.92%
View complete list of ABCELLERA BIOLOGICS INC shareholders